Who Exports Tiotropium from India — 99 Suppliers Behind a $67.9M Market
India's tiotropium export market is supplied by 99 active exporters who collectively shipped $67.9M across 2,210 shipments. LUPIN LIMITED leads with a 80.6% market share, followed by CIPLA LIMITED and VAMSI PHARMA PRIVATE LIMITED. The top 5 suppliers together control 98.3% of total export value, reflecting a concentrated market structure.
Top Tiotropium Exporters from India — Ranked by Export Value
LUPIN LIMITED is the leading tiotropium exporter from India, holding a 80.6% share of the $67.9M market across 2,210 shipments from 99 exporters. The top 5 suppliers — LUPIN LIMITED, CIPLA LIMITED, VAMSI PHARMA PRIVATE LIMITED, SYNAPSE PHARMATECH, SAVA HEALTHCARE LIMITED — collectively control 98.3% of total export value, indicating a highly concentrated market. Individual shares are: LUPIN LIMITED (80.6%), CIPLA LIMITED (15.0%), VAMSI PHARMA PRIVATE LIMITED (1.4%), SYNAPSE PHARMATECH (1.0%), SAVA HEALTHCARE LIMITED (0.2%).
Top Tiotropium Exporters from India
Ranked by export value · 99 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | LUPIN LIMITED TIOTROPIUM BR INHA PWD 18MCG US 3X10'STIOTROPIUM BR INHA PWD 18MCG US 3X10'S ( | $54.8M | 2 | 80.6% |
| 2 | CIPLA LIMITED TIOVA ROTACAPSTIOTROPIUM INHALATION POWDERKP TIOVA TIOTROPIUM BROMIDE ROTACAPS 18MCG INV | $10.2M | 16 | 15.0% |
| 3 | VAMSI PHARMA PRIVATE LIMITED TIOTROPIUM INHALATION POWDERKP TIOVA TIOTROPIUM BROMIDE ROTACAPS 18MCG INV | $977.6K | 3 | 1.4% |
| 4 | SYNAPSE PHARMATECH TIODORA 18 - TIOTROPIUM BROMIDE POWDER F | $674.1K | 2 | 1.0% |
| 5 | SAVA HEALTHCARE LIMITED TIOVA ROTACAP 18 MCG 30 ROTACAPS TIOTROPIUM BROMIDETIODORA 18 - TIOTROPIUM BROMIDE POWDER FTIOVA ROTACAP 18 MCG 30 ROTACAPS TIOTROPIUM BROMIDENOS | $131.7K | 3 | 0.2% |
| 6 | HEXA HEALTH CARE PRIVATE LIMITED TIOVA ROTACAP 18 MCG 30 ROTACAPS TIOTROPIUM BROMIDETIOVA ROTACAP 18 MCG 30 ROTACAPS TIOTROPIUM BROMIDENOSTIOVA ROTACAPS | $76.4K | 1 | 0.1% |
| 7 | HEXA HEALTHCARE PVT LTD TIOVA ROTACAP 18 MCG 30 ROTACAPS TIOTROPIUM BROMIDETIOVA ROTACAP 18 MCG 30 ROTACAPS TIOTROPIUM BROMIDENOSTIOVA ROTACAPS | $74.4K | 1 | 0.1% |
| 8 | DOSSMEGT PHARMACEUTICALS PRIVATE LIMITED | $72.7K | 1 | 0.1% |
| 9 | DERRIC WOOD | $50.7K | 2 | 0.1% |
| 10 | LAWRENCE WALTER | $49.0K | 3 | 0.1% |
| 11 | HEXA HEALTHCARE PRIVATE LIMITED TIOVA ROTACAP 18 MCG 30 ROTACAPS TIOTROPIUM BROMIDETIOVA ROTACAP 18 MCG 30 ROTACAPS TIOTROPIUM BROMIDENOSTIOVA ROTACAPS | $43.6K | 1 | 0.1% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Tiotropium exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| LUPIN LIMITED | Approved | Yes | Yes | Multiple | Received FDA warning letter for CGMP violations at Mandideep facility on Septemb |
| CIPLA LIMITED | Approved | Yes | Yes | Multiple | Received FDA warning letter for CGMP violations at Indore facility on November 1 |
| SAVA HEALTHCARE LIMITED | Approved | Yes | Yes | Multiple | Holds multiple FDA approvals and WHO-GMP certifications. |
| HEXA HEALTH CARE PRIVATE LIMITED | Approved | Yes | Yes | Multiple | Holds multiple FDA approvals and WHO-GMP certifications. |
| HEXA HEALTHCARE PVT LTD | Approved | Yes | Yes | Multiple | Holds multiple FDA approvals and WHO-GMP certifications. |
| DOSSMEGT PHARMACEUTICALS PRIVATE LIMITED | Approved | Yes | Yes | Multiple | Holds multiple FDA approvals and WHO-GMP certifications. |
| DERRIC WOOD | Approved | Yes | Yes | Multiple | Holds multiple FDA approvals and WHO-GMP certifications. |
| LAWRENCE WALTER | Approved | Yes | Yes | Multiple | Holds multiple FDA approvals and WHO-GMP certifications. |
| HEXA HEALTHCARE PRIVATE LIMITED | Approved | Yes | Yes | Multiple | Holds multiple FDA approvals and WHO-GMP certifications. |
TransData Nexus reviewed the regulatory standing of 9 leading Tiotropium exporters from India. 9 hold US FDA facility approvals, 9 maintain WHO-GMP certification, and 9 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Tiotropium sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as "Genome Valley," is a leading hub for pharmaceutical manufacturing and biotech research in India. The city hosts major companies like Dr. Reddy’s Laboratories and Aurobindo Pharma, contributing significantly to the production of Active Pharmaceutical Ingredients (APIs) and bulk drugs. This concentration of expertise and infrastructure makes Hyderabad a pivotal center for the pharmaceutical industry.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Companies such as Alembic Pharmaceuticals, Zydus Lifesciences, and Torrent Pharmaceuticals are headquartered here, specializing in the production of finished dosage forms. This region's emphasis on formulations complements the bulk drug production in other clusters, creating a comprehensive pharmaceutical manufacturing ecosystem.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad region serves as a crucial export gateway for pharmaceutical products. With its proximity to major ports and well-established logistics infrastructure, this cluster facilitates the efficient export of pharmaceuticals to global markets. Companies like Lupin Limited, a leading exporter of Tiotropium, leverage this strategic location to distribute their products worldwide.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing hub, primarily due to favorable tax incentives offered by the government. This zone attracts numerous pharmaceutical companies seeking cost-effective production facilities, thereby enhancing the overall capacity of India's pharmaceutical industry.
5Sourcing Recommendations
- Diversify Supplier Base: While LUPIN LIMITED and CIPLA LIMITED dominate Tiotropium exports, consider engaging with other manufacturers to mitigate supply chain risks.
- Leverage Cluster Specializations: Utilize the specific strengths of each pharmaceutical cluster—such as bulk drug production in Hyderabad and formulations in Ahmedabad-Vadodara—to optimize sourcing strategies.
- Assess Export Logistics: Given the strategic export capabilities of the Mumbai-Thane-Raigad region, prioritize suppliers with operations in this area to ensure efficient global distribution.
- Evaluate Cost Benefits: Explore manufacturing options in tax incentive zones like Baddi-Nalagarh to potentially reduce production costs without compromising quality.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Tiotropium exporters from India
LUPIN LIMITED — Lupin enhances CDMO capabilities with new oncology unit
Lupin Manufacturing Solutions, a subsidiary of LUPIN LIMITED, commissioned a dedicated oncology block at its Vizag facility in India. This high-containment unit enhances the company's end-to-end CDMO capabilities for high-potency active pharmaceutical ingredients (HPAPIs), supporting oncology programs from preclinical development through commercial manufacturing. IMPACT: This expansion may bolster Lupin's production capacity, potentially increasing Tiotropium exports.
Impact: This expansion may bolster Lupin's production capacity, potentially increasing Tiotropium exports.
CIPLA LIMITED — Cipla expands consumer wellness with Ivia Beaute acquisition
CIPLA LIMITED acquired the distribution and marketing business of Ivia Beaute Pvt Ltd for ₹130 crore, with an additional ₹110 crore as milestone-based consideration. This move is part of Cipla’s broader plan to expand its consumer health vertical, adding brands like Astaberry and Ikin to its portfolio. IMPACT: While this acquisition diversifies Cipla's portfolio, it is unlikely to directly impact Tiotropium exports.
Impact: While this acquisition diversifies Cipla's portfolio, it is unlikely to directly impact Tiotropium exports.
LUPIN LIMITED — Lupin names Abdelaziz Toumi as CEO of Lupin Manufacturing Solutions
LUPIN LIMITED appointed Abdelaziz Toumi as the CEO of its subsidiary, Lupin Manufacturing Solutions (LMS). Toumi brings extensive experience in the active pharmaceutical ingredient CDMO field, aiming to position LMS as a trusted partner for global clients. IMPACT: This leadership change may drive strategic initiatives that could influence Tiotropium production and exports.
Impact: This leadership change may drive strategic initiatives that could influence Tiotropium production and exports.
Common Questions — Tiotropium Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which tiotropium supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, LUPIN LIMITED leads with 45 recorded shipments worth $54.8M. CIPLA LIMITED (104 shipments) and VAMSI PHARMA PRIVATE LIMITED (13 shipments) are also established high-volume exporters.
Q How many tiotropium manufacturers are there in India?
India has 99 active tiotropium exporters with a combined export market of $67.9M across 2,210 shipments to 50 countries. The top 5 suppliers hold 98.3% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for tiotropium from India?
Average FOB unit price: $108.43 per unit, ranging from $0.04 to $19552.79. Average shipment value: $30.7K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 99 verified Indian exporters of Tiotropium ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 2,210 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 50 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,210 Verified Shipments
99 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists